Critical Reviews in Oncology/Hematology 54 (2005) 253

Subject index

Volume 54 (2005)

Aged > 80 54, 137Aged 54, 137Alemtuzumab 54, 11Angiogenesis research 54, 53Array analyses 54, 95

Bevacizumab 54, 11

Cancer 54, 11, 85, 243Cancer registry 54, 117Cancer survival 54, 117Carcinoma of the cervix 54, 197Carcinoma of unknown primary 54, 243Cell communication 54, 107Cetuximab 54, 11Chemoprevention 54, 1Chemotherapy 54, 137, 145, 165, 197, 209c-Kit 54, 63Clinical trials 54, 165Cognitive assessment 54, 137Colorectal cancer 54, 145Comprehensive geriatric assessment 54, 129COX-2 54, 1CTL 54, 107

Decision making process 54, 165DNA repair 54, 171Drug metabolism 54, 171Drug response 54, 171Drug toxicity 54, 171Drug transport 54, 171Dutasteride 54, 1

Elderly 54, 117, 145, 157Epidemiology 54, 77Epo 54, 63Epo-R 54, 63

Finasteride 54, 1

Gastric cancer 54, 209Gemtuzumab-ozogamicin 54, 11Gene polymorphisms 54, 171Gene profiling 54, 95Geriatric assessment 54, 129Geriatric screening 54, 129Geriatrics 54, 157, 77Green tea 54, 1Guidelines 54, 165

Ibritumomab 54, 11ITP 54, 107

Lycopene 54, 1

Megakaryocytopoiesis 54, 107Microarrays 54, 95Microcog 54, 137Monoclonal antibody therapy 54, 11

Pain 54, 157Post-ubiquitylation mechanisms 54, 31Prostate Cancer Prevention Trial 54, 1Prostate cancer 54, 1Proteasome 54, 31Protein degradation 54, 31Proteolysis 54, 31Public health 54, 117

Radiotherapy 54, 197Review 54, 11, 145, 209Rituximab 54, 11

SCF 54, 63Selective estrogen receptor modulators 54, 1Selenium and Vitamin E Cancer Prevention Trial 54, 1Selenium 54, 1Senescence 54, 85Signal transduction 54, 63Single nucleotide polymorphisms 54, 171Socio-economic factors 54, 117Soft tissue sarcoma 54, 77Soy 54, 1Stage IV 54, 145Surgery 54, 197, 209

Telomerase 54, 85Telomere 54, 85Th1/Th2 balance 54, 107Time-related parameters 54, 165Tolerance failure 54, 107Tositumomab 54, 11Transformation 54, 85Trastuzumab 54, 11Treatment 54, 209, 77Tumor therapy 54, 53Tumor vascularization 54, 53Tumour 54, 243

Ubiquitin 54, 31

Vitamin D 54, 1Vitamin E 54, 1

doi:10.1016/S1040-8428(05)00068-5